Genetic targeting of sprouting angiogenesis using Apln-CreER

利用 Apln-CreER 进行发芽血管生成的基因靶向

阅读:5
作者:Qiaozhen Liu, Tianyuan Hu, Lingjuan He, Xiuzhen Huang, Xueying Tian, Hui Zhang, Liang He, Wenjuan Pu, Libo Zhang, Heng Sun, Jing Fang, Ying Yu, Shengzhong Duan, Chaobo Hu, Lijian Hui, Haibin Zhang, Thomas Quertermous, Qingbo Xu, Kristy Red-Horse, Joshua D Wythe, Bin Zhou

Abstract

Under pathophysiological conditions in adults, endothelial cells (ECs) sprout from pre-existing blood vessels to form new ones by a process termed angiogenesis. During embryonic development, Apelin (APLN) is robustly expressed in vascular ECs. In adult mice, however, APLN expression in the vasculature is significantly reduced. Here we show that APLN expression is reactivated in adult ECs after ischaemia insults. In models of both injury ischaemia and tumor angiogenesis, we find that Apln-CreER genetically labels sprouting but not quiescent vasculature. By leveraging this specific activity, we demonstrate that abolishment of the VEGF-VEGFR2 signalling pathway as well as ablation of sprouting ECs diminished tumour vascularization and growth without compromising vascular homeostasis in other organs. Collectively, we show that Apln-CreER distinguishes sprouting vessels from stabilized vessels in multiple pathological settings. The Apln-CreER line described here will greatly aid future mechanistic studies in both vascular developmental biology and adult vascular diseases.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。